Jacobs Levy Equity Management’s Cardiovascular Systems, Inc. CSII Stock Holding History

Jacobs Levy Equity Management’s Portfolio CSII Stock Details CSII Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-170,363	Closed	-$2.32M	–	1098
2022 Q4	$2.32M	Sell	170,363 -699	-0.4%	-$9.7K	0.02%	526
2022 Q3	$2.37M	Buy	171,062 +15,261	+10%	+$227K	0.02%	530
2022 Q2	$2.24M	Sell	155,801 -39,435	-20%	-$684K	0.02%	577
2022 Q1	$4.41M	Buy	195,236 +86,514	+80%	+$1.68M	0.03%	453
2021 Q4	$2.04M	Sell	108,722 -17,728	-14%	-$473K	0.01%	618
2021 Q3	$4.15M	Buy	126,450 +632	+0.5%	+$23.6K	0.03%	474
2021 Q2	$5.37M	Sell	125,818 -90,050	-42%	-$3.52M	0.04%	417
2021 Q1	$8.28M	Sell	215,868 -5,586	-3%	-$238K	0.06%	328
2020 Q4	$9.7M	Sell	221,454 -6,370	-3%	-$240K	0.09%	268
2020 Q3	$8.96M	Buy	227,824 +5,775	+3%	+$187K	0.09%	225
2020 Q2	$7.01M	Sell	222,049 -50,161	-18%	-$1.87M	0.08%	281
2020 Q1	$9.6M	Sell	272,210 -11,752	-4%	-$495K	0.12%	190
2019 Q4	$13.8M	Buy	283,962 +45,618	+19%	+$2.08M	0.14%	190
2019 Q3	$11.3M	Sell	238,344 -3,240	-1%	-$152K	0.14%	193
2019 Q2	$10.4M	Buy	241,584 +18,181	+8%	+$706K	0.14%	185
2019 Q1	$8.64M	Buy	223,403 +60,810	+37%	+$2.06M	0.12%	214
2018 Q4	$4.63M	Buy	162,593 +18,160	+13%	+$577K	0.08%	278
2018 Q3	$5.65M	Buy	144,433 +15,963	+12%	+$590K	0.08%	288
2018 Q2	$4.16M	Sell	128,470 -13,410	-9%	-$369K	0.07%	346
2018 Q1	$3.11M	Sell	141,880 -14,590	-9%	-$351K	0.05%	379
2017 Q4	$3.71M	Buy	156,470 +13,150	+9%	+$332K	0.07%	331
2017 Q3	$4.03M	Buy	143,320 +5,080	+4%	+$155K	0.08%	287
2017 Q2	$4.46M	Buy	138,240 +230	+0.2%	+$7.01K	0.1%	251
2017 Q1	$3.9M	Buy	138,010 +7,810	+6%	+$207K	0.08%	298
2016 Q4	$3.15M	Buy	130,200 +83,392	+178%	+$2.05M	0.06%	326
2016 Q3	$1.11M	Buy	+46,808	New	+$1.02M	0.02%	556
2015 Q2	–	Sell	-6,960	Closed	-$272K	–	874
2015 Q1	$272K	Buy	+6,960	New	+$240K	﹤0.01%	659

Other funds holding CSII

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return

Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Water Island Capital New York $1.08B AUM 105.75% 1-Year Est. Return

Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Gabelli Funds Rye, New York $15.7B AUM 36.4% 1-Year Est. Return

Jacobs Levy Equity Management's CSII Position: Q1 2023 in Review

Jacobs Levy Equity Management sold out of Cardiovascular Systems, Inc. (CSII) in Q1 2023, closing a stake of 170,363 shares — an estimated $2.32M sold.

Jacobs Levy Equity Management first reported a position in CSII in Q1 2015 and held it in 27 quarters. The position peaked at $13.8M in Q4 2019. 150 funds tracked by Wall St. Rank hold CSII as of Q1 2023.

Jacobs Levy Equity Management reported no remaining Cardiovascular Systems, Inc. position as of Q1 2023 after selling out during the quarter.
Jacobs Levy Equity Management sold 170,363 Cardiovascular Systems, Inc. shares in Q1 2023, an estimated $2.32M.
Jacobs Levy Equity Management first reported a position in Cardiovascular Systems, Inc. in Q1 2015 and held it in 27 quarters.
Jacobs Levy Equity Management's Cardiovascular Systems, Inc. position peaked at $13.8M in Q4 2019.
150 funds tracked by Wall St. Rank held Cardiovascular Systems, Inc. as of Q1 2023.

Based on Jacobs Levy Equity Management's 13F filing for Q1 2023, filed 15 May 2023.